The text provided includes financial information about The Procter & Gamble Company for the three and six months ended December 31, including consolidated statements of earnings, comprehensive income, balance sheets, and shareholders' equity. It further details the company's segment information, goodwill, intangible assets, and earnings per share calculations. Additionally, it discusses various financial matters such as share-based compensation, risk management activities, fair value measurements, accumulated other comprehensive income/(loss), commitments, and contingencies. The text also covers details on litigation, income tax uncertainties, and financial instruments used in hedging transactions. These aspects collectively provide an overview of the financial standing and operations of The Procter & Gamble Company as of December 31.
The text provided discusses Management's Discussion and Analysis of Financial Condition and Results of Operations for a company, detailing forward-looking statements, risks, uncertainties, business segments, results of operations, and financial measures such as organic sales growth, adjusted free cash flow, and core earnings per share. It elaborates on the company's performance in various segments like Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care for the second quarter and six months ended December 31, 2022. The analysis includes changes in net sales, net earnings, market shares, costs, and cash flow activities such as operating, investing, and financing. Moreover, it provides a reconciliation of non-GAAP measures like organic sales growth, adjusted free cash flow, and core earnings per share with their GAAP counterparts, defining these metrics and their importance for investors and management decision-making. Management aims to use these measures to assess business performance, allocate financial resources, and plan for future growth and investment opportunities.
There have been no significant changes in the Company's market risk exposure since June 30, 2022. More details are available in Note 9 of the Consolidated Financial Statements regarding Risk Management Activities and Fair Value Measurements.
The text provided discusses the evaluation of disclosure controls and procedures at a company, with the Chairman of the Board and the Chief Financial Officer concluding that the controls and procedures were effective in ensuring the required disclosure of information in reports filed under the Securities Exchange Act of 1934. Additionally, it mentions that there were no significant changes in the company's internal control over financial reporting during the fiscal quarter ended December 31, 2022.
The text provides information on legal proceedings that the company is subject to, covering various matters such as antitrust, product liability, contracts, etc. SEC regulations mandate disclosure of environmental proceedings involving governmental authorities with potential monetary sanctions exceeding $1 million, which are not applicable in this instance as there are no relevant matters to disclose for the specified period.
The text provides a reference to the risk factors section in the Company's Form 10-K for the fiscal year ended June 30, 2022. This section likely outlines the potential risks and uncertainties that could impact the company's business operations and financial performance.
The text discusses the unregistered sales of equity securities by a company over a period from October 1, 2022, to December 31, 2022. During this period, the company purchased a total of 14,414,553 shares at varying average prices per share. The purchases were part of publicly announced plans, with the company mentioned to be expecting further reductions in outstanding shares through direct share repurchases in fiscal year 2023, with a budget of $6 to $8 billion. The share repurchases are authorized by the company's Board of Directors and are expected to be financed through a combination of operating cash flows and debt issuance.
I'm here to help! Please provide the text you would like me to summarize.
I apologize, but I cannot respond to your request without the text you would like me to summarize. Please provide me with the text you would like me to summarize.
I am ready to assist. Please provide the text for me to summarize.
The text describes various exhibits related to the company, including amended articles of incorporation, regulations, a summary of the short term achievement reward program, and certifications by the Chief Executive Officer and Chief Financial Officer. Additionally, there are Inline XBRL taxonomy extension documents and a cover page interactive data file. The report is signed by the Senior Vice President and Chief Accounting Officer of The Procter & Gamble Company on January 19, 2023.
